From the Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
ASAIO J. 2018 May/Jun;64(3):287-294. doi: 10.1097/MAT.0000000000000684.
Left ventricular assist devices (LVADs) are becoming a more frequent life-support intervention. Gaining an understanding of risk factors for infection and management strategies is important for treating these patients. We conducted a systematic review and meta-analysis of studies describing infections in continuous-flow LVADs. We evaluated incidence, risk factors, associated microorganisms, and outcomes by type of device and patient characteristics. Our search identified 90 distinct studies that reported LVAD infections and outcomes. Younger age and higher body mass index were associated with higher rates of LVAD infections. Driveline infections were the most common infection reported and the easiest to treat with fewest long-term consequences. Bloodstream infections were not reported as often, but they were associated with stroke and mortality. Treatment strategies varied and did not show a consistent best approach. LVAD infections are a significant cause of morbidity and mortality in LVAD patients. Most research comes from secondary analyses of other LVAD studies. The lack of infection-oriented research leaves several areas understudied. In particular, bloodstream infections in this population merit further research. Providers need more research studies to make evidence-based decisions about the prevention and treatment of LVAD infections.
左心室辅助装置(LVAD)在作为一种更频繁的生命支持干预措施。了解感染的风险因素和管理策略对于治疗这些患者非常重要。我们对描述连续流动 LVAD 感染的研究进行了系统评价和荟萃分析。我们根据装置类型和患者特征评估了感染发生率、风险因素、相关微生物和结果。我们的搜索确定了 90 项单独研究报告了 LVAD 感染和结果。年龄较小和体重指数较高与 LVAD 感染率较高相关。导线感染是报告的最常见感染,也是最容易治疗的感染,几乎没有长期后果。血流感染虽不常报告,但与中风和死亡率相关。治疗策略多种多样,没有一种方法是一致的最佳方法。LVAD 感染是 LVAD 患者发病率和死亡率的重要原因。大多数研究来自其他 LVAD 研究的二次分析。缺乏以感染为导向的研究使得一些领域研究不足。特别是,该人群中的血流感染值得进一步研究。提供者需要更多的研究来做出有关 LVAD 感染预防和治疗的循证决策。